Newsletter | February 3, 2025

02.03.25 -- Training Specifically For Tech Transfer Skills Does Exist

SPONSOR

Webinar: Essential Considerations for Selecting the Right Biologic Fill/Finish Partner

Choosing the right Fill/Finish partner ensures drug safety and operational efficiency. A reliable partner minimizes risk, prevents contamination, and improves yield, ultimately saving costs. This webinar highlights four key questions to identify a quality-focused provider. Key takeaways include reducing risks while increasing yield, assessing partner quality, and understanding the value of an experienced partner in meeting therapeutic goals. Click here to learn more.

FEATURED EDITORIAL

Training Specifically For Tech Transfer Skills Does Exist

Professionals within our development and manufacturing outsourcing ecosystem are quite worried about inadequate training – in-house at their biotechs, and at their CDMOs. A main concern is a lack of sufficiently trained personnel to perform the various technology transfers to keep our outsourcing industry running efficiently.

Developing ADCs? Here's A Refresher On HPAPI Health Risk Mitigation

API payloads used in antibody-drug conjugates are some of the most potent substances in biopharma, so it's important to protect workers who handle them.

INDUSTRY INSIGHTS

Demonstrating Technical Excellence In Contract Manufacturing

Tech Talks explore ADC development innovations, including integrated supply chains, seamless pilot-to-GMP scale-ups, and advanced process analytical technology (PAT).

The Benefits Of End-To-End Formulation And Fill/Finish Of Biologics

Proper formulation development has a huge impact on whether a technology transfer to clinical phase fill/finish is successful. Review the challenges of transitioning a promising drug candidate.

Development And Manufacturing Of Vaccines Containing Aluminum Adjuvants

Incorporating adjuvants like aluminum salts into vaccines offers several benefits, but it's crucial to understand the challenges of these formulations to ensure a successful partnership with a CDMO.

How A Drug's Molecule Type Affects Several Bioanalysis Parameters

Discover why bioanalytics are crucial to selecting promising drug candidates during development and to characterizing the pharmacokinetic and pharmacodynamic profile of the drug in early clinical trials.

Immunogenicity Risk Assessment In Drug Candidate Selection

Identify and address potential anti-drug immune responses early in development to streamline your drug’s path to clinical success — start smart and finish fast.

Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics

Unlock the potential of antibody-drug conjugates (ADCs) by exploring our novel payloads, designed for easy access and evaluation, to accelerate your ADC drug development with proven efficacy and safety.

Charting A Successful CMC Journey For Your ADC Drug Product

Learn about best practices and strategies to optimize bioconjugate drug product tech transfers and supplies in clinical or commercial phase, and explore real-world case studies.

Meeting An Expedited Antibiotic Project Timeline

A company needed to produce the registration batches of a generic broad-spectrum antibiotic. See how an experienced CDMO helped meet the unprecedented four-month timeline.

Wrap-Around Labeler Ideal For Small Vials, Cartridges And Syringes

Discover a reliable solution for labeling small batches of medical products, including vials, syringes, and cartridges, that fully automatic machines struggle to handle.

Sustainability Considerations For Drug Delivery Device End-To-End Solutions

Successfully address the gradual unlinking of economic activity from the consumption of finite resources and the removal of waste to support and help prevent a global climate catastrophe.

SOLUTIONS

European Center Of Excellence For Clinical Biologics

Our proven expertise and simplified execution with development, filling, and analytical under one roof ensure safe, efficacious products reach patients needing care.

Formulation Development: The Key To Product Stability

Biopharmaceutical development hinges on a robust CMC strategy. Our expertise allows us to collaboratively design the optimal suite of analytical studies tailored to your specific molecule.

Cytovance Biologics Analytical Development Services

What does it take to develop the products going into clinical trials? Our mission at Cytovance Biologics is to offer responsive, reliable, and resourceful services that help our customers reach their goals.

Capacity Update July 2024: Large Molecule Development

Gain insights into boosting efficiency, fostering innovation, and how integrated capabilities generate value for innovators.

Live Biotherapeutics And Next Gen Manufacturing

With services to develop and scale up Probiotics, Postbiotics and Microbial Therapeutics, explore how Sacco System’s capabilities can help take your drug product to market safely and efficiently.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: